Comparison of clinicopathological characteristics, efficacy of neoadjuvant therapy, and prognosis in HER2-low and HER2-ultralow breast cancer

• मुख्य लेखकों: Feng Guan (लेखक), Xianli Ju (लेखक), Lixia Chen (लेखक), Jiacai Ren (लेखक), Xiaokang Ke (लेखक), Bin Luo (लेखक), Aoling Huang (लेखक), Jingping Yuan (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: BMC, 2024-09-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Background This study aims to analyze potential differences in clinicopathology, efficacy of neoadjuvant therapy (NAT), and clinical outcome among HER2-null, HER2-ultralow and HER2-low breast cancers. Methods Consecutive cases of HER2-negative breast cancer that received NAT were included....